Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 31;12(3):e1001779.
doi: 10.1371/journal.pmed.1001779. eCollection 2015 Mar.

UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age

Cathie Sudlow  1 , John Gallacher  2 , Naomi Allen  3 , Valerie Beral  4 , Paul Burton  5 , John Danesh  6 , Paul Downey  7 , Paul Elliott  7 , Jane Green  4 , Martin Landray  4 , Bette Liu  8 , Paul Matthews  7 , Giok Ong  9 , Jill Pell  10 , Alan Silman  11 , Alan Young  4 , Tim Sprosen  4 , Tim Peakman  12 , Rory Collins  3
Affiliations

UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age

Cathie Sudlow et al. PLoS Med. .

Abstract

Cathie Sudlow and colleagues describe the UK Biobank, a large population-based prospective study, established to allow investigation of the genetic and non-genetic determinants of the diseases of middle and old age.

PubMed Disclaimer

Conflict of interest statement

All authors are current or past members of UK Biobank’s executive management team or steering committee, or of one of UK Biobank’s working groups. PM is a part-time employee and holder of stock and options in GlaxoSmithKline and has received attendance fees and contributed to panels convened by the Medical Research Council, a public funder of UK Biobank. JD has received research funding from The Wellcome Trust, British Heart Foundation, UK Medical Research Council, BUPA Foundation, Denka, diaDexus, European Research Council, European Union, Evelyn Trust, Fogarty International Centre, GlaxoSmithKline, Merck, National Heart, Lung and Blood Institute, National Health Service Blood and Transplant, National Institute for Health Research, National Institute of Neurological Disorders and Stroke, Novartis, Pfizer, Roche, UK Biobank. RC is the CEO and PI of UK Biobank, which is a charity set up by the MRC and Wellcome Trust to establish this prospective cohort as a resource for researchers from around the world. RC is a member of the Editorial Board of PLOS Medicine. All other authors have declared that no competing interests exist.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Clayton D, McKeigue PM (2001). Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358: 1356–1360. - PubMed
    1. Willett WC, Blot WJ, Colditz GA, Folsom AR, Henderson BE, Stampfer MJ (2007). Merging and emerging cohorts: not worth the wait. Nature 445: 257–258. - PubMed
    1. Collins FS, Manolio TA (2007). Merging and emerging cohorts: necessary but not sufficient. Nature 445: 259 - PubMed
    1. Doll R, Peto R (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Journal of the National Cancer Institute 66: 1191–1308. - PubMed
    1. Ollier W, Sprosen T, Peakman T (2005). UK Biobank: from concept to reality. Pharmacogenomics 6: 639–646. - PubMed

Publication types